Health
New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation – News-Medical.Net
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million…
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.
The grant will aid the effort to bring further preclinical validation to the AAV vaccine platform. An AAVCOVID vaccine candidate is set to enter clinical trials in 2021.
The AAVCOVID vaccine program was founded at Mass General Brigham at the outset of the pandemic.
Preliminary tests of the vaccines’…
-
Noosa News11 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General20 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Business7 hours agoWhere next for the CBA share price?
-
General22 hours agoRed tape on chopping block in bid to build homes faster